Spring Educational Conference: Featuring Dr. Dana Deupree
The Macular Degeneration Association hosts its spring educational conference in Tampa, Florida, this year, and Dr. Dana Deupree, a noted ophthalmologist in the macular degeneration field, is one of the conference's featured speakers.
- Sarasota-Bradenton, FL (1888PressRelease) March 18, 2011 - MACULAR DEGENERATION ASSOCIATION (MDA)
2011 SPRING EDUCATIONAL CONFERENCE
ADVANCES IN THE TREATMENT OF WET AND DRY MACULAR DEGENERATION,
WHAT PATIENTS SHOULD KNOW!
Featuring Dr. Dana Deupree
Tampa Westshore Marriott - Tampa, Florida
Saturday, March 26, 2011
8:30 A.M. - 5:00 P.M.
Program Chair: Dr. Michael Tolentino
The Macular Degeneration Association hosts its spring educational conference in Tampa, Florida, this year, and Dr. Dana Deupree, a noted ophthalmologist in the macular degeneration field, is one of the conference's featured speakers. Dr. Deupree will explain what doctors examine during a patient's office visit, introduce alternative therapies for macular degeneration, and offer advice to patients about the types of questions to ask during an office visit. Dr. Deupree will make himself available to the patients by actively participating in the panel discussion. This event is a unique opportunity to learn about the latest advances in macular degeneration research, genetic testing, medications, treatments, and therapies. Participants are encouraged to share questions, concerns and ideas with nationally known macular experts, local doctors, patients and caregivers.
Dr. Deupree is a board-certified ophthalmologist specializing in diseases of the vitreous and retina. He received his medical degree from the American University of the Caribbean in 1983. Dr. Deupree received a grant from the National Eye Institute and researched diabetic eye disease while serving as a Harvard Research Fellow. His sub-specialties include medical and surgical management of macular disorders, diabetic retinopathy, complex retinal detachments, and trauma. His current research interest is Rheopheresis treatment for macular degeneration, among others. Currently, he is the principal researcher in a phase three FDA clinical trial. He runs a solo practice, The Macula Center in Palm Harbor, Fl. This center is exclusively devoted to treating the retina and macula. He is a fellow of the American Academy of Ophthalmology and the American College of Surgeons.
The conference will have general session presentations beginning in the morning that will continue throughout the day, exhibition sessions during the sponsored breaks, and a question and answer session at the conclusion of the conference. Presentations will be given by prominent macular degeneration physicians and clinicians, including: Dr. Michael Tolentino, Dr. Sonya Braudway, Dr. Dana Deupree, Dr. Karen Gehrs, Dr. Benjamin Kim, Dr. Brian Madow, etc. Patients and their caregivers will also be given the opportunity to participate in a panel discussion and a meet and greet with the doctors.
Program Topics include:
• Opening Remarks: MDA Chairman, Lawrence Hoffheimer
• What is Macular Degeneration?
• What is Examined in the Doctor's Office?
• Current Treatments for Dry Macular Degeneration
• Future Treatments for Dry Macular Degeneration
• Clinical Trials offered for treating Dry Macular Degeneration
• Current Treatment for Wet Macular Degeneration
• Future Treatments for Wet Macular Degeneration
• Genetic Testing
• New Telescope Implant
• Low Vision
• Alternative Therapies
• Questions Patients are Embarrassed to Ask Their Doctor (panel)
About the Macular Degeneration Association (MDA)
The Macular Degeneration Association (MDA) is a nonprofit health organization dedicated to educating and empowering age-related macular degeneration patients all across the world.
Age-related macular degeneration is an increasingly prevalent degenerative eye disease, affecting millions of aging seniors. The mission of MDA is to educate patients on the latest advances in treating age-related macular degeneration (AMD). However, our focus extends far beyond diagnosed patients. We are committed to the senior population at large, those most at risk of developing macular degeneration.
Our goal is to provide information about risk factors, genetic predisposition, and proper diagnosis, as well as preventative efforts and treatment options that will likely reduce the most adverse effect of AMD, blindness.
MDA is passionate about funding and developing sophisticated patient education and advocacy programs designed to improve macular patients' quality of life. This is accomplished through the Association's patient education conferences and seminars held nationwide.
The Association honors its commitment to prioritizing patient education by aligning itself with experts in the macular field, investigating retina-related scientific breakthroughs, and disseminating new scientific advances to macular patients across the world.
We strongly believe that providing support, education and empowerment to the millions of people living with age-related macular degeneration will improve patient quality of life, and energize the retina field to develop advances in treating AMD. It is our hope that encouraging knowledge and awareness will ultimately lead to a cure.
The money raised by the foundation funds research, information programs, advocacy and awareness efforts that will support the over 9.1 million people with macular degeneration in communities across America. For more information, please visit our website at www.maculardegenerationassociation.org.
To register or for more information about the March 26th Educational Conference, please contact Ms. Rosa Seminario at: rseminario ( @ ) maculardegenerationassociation dot org or call (800) 869-1551 ext.0. Thank you for your interest and support.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam